The Oncotype DX® Breast test to guide management of nodepositive oestrogen receptor-positive HER2-negative breast cancer patients: the United Kingdom experience. (March 2019) - Battisti, N.M.L.; Gutteridge, E.; Mylvaganam, S.; Parton, M.; Ring, A.; McGrath, S.E.